Figure 2From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial Kaplan-Meier survival curve of time to first intravenous device complication per patient (log rank, P = 0.53).Back to article page